RadImmune Therapeutics, Inc.
Funding rounds
1 counted as startup funding. Open the number of investors for the round's details.
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| Aug 2019 | $14 M | No. 1 | $10 to $50 million | equity | SEC |
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
RadImmune Therapeutics, Inc. chose not to state its revenue in its newest notice of a funding round (Aug 2019).
SEC Form D · Aug 2019
The industry group it chose in its notices: Other Health Care.
SEC Form D · Aug 2019
Products and services#
No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).
Investors#
No investor of RadImmune Therapeutics, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Jack Hidary | Executive officer | Aug 2019 |
| Jack Hidary | Director | Aug 2019 |
| Josh Becker | Director | Aug 2019 |
| Ron Lennox | Director | Aug 2019 |